CY1113577T1 - ΣΥΝΘΕΣΗ ΔΙΥΔΡΟΘΕΙΕΝΟ[3,2-d]ΠΥΡΙΜΙΔΙΝΟ ΔΙΟΛΩΝ ΚΑΙ ΠΑΡΟΜΟΙΩΝ ΠΥΡΙΜΙΔΙΝΟ ΔΙΟΛΩΝ - Google Patents
ΣΥΝΘΕΣΗ ΔΙΥΔΡΟΘΕΙΕΝΟ[3,2-d]ΠΥΡΙΜΙΔΙΝΟ ΔΙΟΛΩΝ ΚΑΙ ΠΑΡΟΜΟΙΩΝ ΠΥΡΙΜΙΔΙΝΟ ΔΙΟΛΩΝInfo
- Publication number
- CY1113577T1 CY1113577T1 CY20121101046T CY121101046T CY1113577T1 CY 1113577 T1 CY1113577 T1 CY 1113577T1 CY 20121101046 T CY20121101046 T CY 20121101046T CY 121101046 T CY121101046 T CY 121101046T CY 1113577 T1 CY1113577 T1 CY 1113577T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pyrimidine
- diol
- diols
- dividroden
- composition
- Prior art date
Links
- 150000002009 diols Chemical class 0.000 title abstract 5
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- YMXFJTUQQVLJEN-UHFFFAOYSA-N pyrimidine Chemical compound C1=CN=CN=C1.C1=CN=CN=C1 YMXFJTUQQVLJEN-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 abstract 2
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 101100296720 Dictyostelium discoideum Pde4 gene Proteins 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 101100082610 Plasmodium falciparum (isolate 3D7) PDEdelta gene Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003230 pyrimidines Chemical class 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με μία βελτιωμένη διεργασία για την παρασκευή διϋδροθειενο[3,2-d]πυριμιδινο διολών, και παρόμοιων πυριμιδινο διολών, που είναι αποδοτική, έχει υψηλή απόδοση, και δεν απαιτεί ακριβά και δυνητικώς ασταθή ενδιάμεσα. Οι διόλες χρησιμοποιούνται ως ενδιάμεσα στη σύνθεση ενώσεων πυριμιδίνης που αναστέλλουν PDE4, και είναι συνεπώς χρήσιμες στην αντιμετώπιση αναπνευστικών ή γαστρεντερικών νόσων και παραπόνων, νόσων και διαταραχών του περιφερικού ή κεντρικού νευρικού συστήματος, φλεγμονωδών καταστάσεων, και καρκίνων.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5281608P | 2008-05-13 | 2008-05-13 | |
| EP09736709A EP2315755B1 (en) | 2008-05-13 | 2009-05-07 | SYNTHESIS OF DIHYDROTHIENO[3,2-d]PYRIMIDINE DIOLS AND SIMILAR PYRIMIDINE DIOLS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113577T1 true CY1113577T1 (el) | 2016-06-22 |
Family
ID=41319263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121101046T CY1113577T1 (el) | 2008-05-13 | 2012-10-31 | ΣΥΝΘΕΣΗ ΔΙΥΔΡΟΘΕΙΕΝΟ[3,2-d]ΠΥΡΙΜΙΔΙΝΟ ΔΙΟΛΩΝ ΚΑΙ ΠΑΡΟΜΟΙΩΝ ΠΥΡΙΜΙΔΙΝΟ ΔΙΟΛΩΝ |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US8471010B2 (el) |
| EP (1) | EP2315755B1 (el) |
| JP (1) | JP5281153B2 (el) |
| KR (1) | KR20110021764A (el) |
| CN (1) | CN102026984B (el) |
| AR (1) | AR071720A1 (el) |
| AU (1) | AU2009246686B2 (el) |
| BR (1) | BRPI0912546A2 (el) |
| CA (1) | CA2722970A1 (el) |
| CL (1) | CL2009001149A1 (el) |
| CO (1) | CO6260135A2 (el) |
| CY (1) | CY1113577T1 (el) |
| DK (1) | DK2315755T3 (el) |
| EA (1) | EA019735B1 (el) |
| EC (1) | ECSP10010571A (el) |
| ES (1) | ES2392920T3 (el) |
| HR (1) | HRP20120860T1 (el) |
| IL (1) | IL208382A0 (el) |
| MA (1) | MA32312B1 (el) |
| ME (1) | ME01465B (el) |
| MX (1) | MX2010011025A (el) |
| MY (1) | MY152292A (el) |
| NZ (1) | NZ588484A (el) |
| PL (1) | PL2315755T3 (el) |
| PT (1) | PT2315755E (el) |
| RS (1) | RS52476B (el) |
| SI (1) | SI2315755T1 (el) |
| TW (1) | TWI421254B (el) |
| UA (1) | UA99964C2 (el) |
| WO (1) | WO2009140127A2 (el) |
| ZA (1) | ZA201006891B (el) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SA08280783B1 (ar) * | 2007-01-11 | 2011-04-24 | استرازينيكا ايه بي | مشتقات بيريدوبيريميدين كمثبطات pde4 |
| US9173884B2 (en) | 2011-11-30 | 2015-11-03 | Trustees Of Boston College | Inhibitors of phosphodiesterase 11 (PDE11) |
| WO2025131986A1 (en) | 2023-12-19 | 2025-06-26 | Boehringer Ingelheim International Gmbh | Novel synthetic steps for the manufacturing method of the pde4b-inhibitor 1-({(5r)-2-[4-(5-chloropyrimidine-2-yl)piperidine-1-yl]-5-oxido-6,7-dihydrothieno[3,2-d]pyrimidine-4-yl}amino)cyclobutyl]methanol |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1470336A1 (de) * | 1962-07-04 | 1969-03-20 | Thomae Gmbh Dr K | Neue Dihydrothieno-[3,4-d]-pyrimidine und Verfahren zu ihrer Herstellung |
| FR2029250A5 (el) * | 1969-01-21 | 1970-10-16 | Roussel Uclaf | |
| TW200410975A (en) * | 2002-09-26 | 2004-07-01 | Nihon Nohyaku Co Ltd | New pesticide and method for using it, new substituted thienopyrimidine derivative, its intermediate, and method for producing it |
| EP1874781B9 (de) * | 2006-04-19 | 2010-09-08 | Boehringer Ingelheim International GmbH | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen |
| US7851468B2 (en) * | 2006-05-15 | 2010-12-14 | Cephalon, Inc. | Substituted pyrazolo[3,4-d]pyrimidines |
-
2009
- 2009-05-07 JP JP2011509563A patent/JP5281153B2/ja active Active
- 2009-05-07 KR KR1020107025268A patent/KR20110021764A/ko not_active Withdrawn
- 2009-05-07 PT PT09736709T patent/PT2315755E/pt unknown
- 2009-05-07 WO PCT/US2009/043068 patent/WO2009140127A2/en not_active Ceased
- 2009-05-07 MX MX2010011025A patent/MX2010011025A/es active IP Right Grant
- 2009-05-07 BR BRPI0912546A patent/BRPI0912546A2/pt not_active IP Right Cessation
- 2009-05-07 ES ES09736709T patent/ES2392920T3/es active Active
- 2009-05-07 EA EA201001775A patent/EA019735B1/ru not_active IP Right Cessation
- 2009-05-07 ME MEP-2012-113A patent/ME01465B/me unknown
- 2009-05-07 CA CA2722970A patent/CA2722970A1/en not_active Abandoned
- 2009-05-07 HR HRP20120860AT patent/HRP20120860T1/hr unknown
- 2009-05-07 DK DK09736709.8T patent/DK2315755T3/da active
- 2009-05-07 CN CN2009801169809A patent/CN102026984B/zh not_active Expired - Fee Related
- 2009-05-07 NZ NZ588484A patent/NZ588484A/en not_active IP Right Cessation
- 2009-05-07 AU AU2009246686A patent/AU2009246686B2/en not_active Ceased
- 2009-05-07 RS RS20120445A patent/RS52476B/sr unknown
- 2009-05-07 US US12/989,575 patent/US8471010B2/en active Active
- 2009-05-07 SI SI200930337T patent/SI2315755T1/sl unknown
- 2009-05-07 EP EP09736709A patent/EP2315755B1/en active Active
- 2009-05-07 MY MYPI20105081 patent/MY152292A/en unknown
- 2009-05-07 PL PL09736709T patent/PL2315755T3/pl unknown
- 2009-05-12 TW TW098115740A patent/TWI421254B/zh not_active IP Right Cessation
- 2009-05-12 CL CL2009001149A patent/CL2009001149A1/es unknown
- 2009-05-12 AR ARP090101712A patent/AR071720A1/es unknown
- 2009-07-05 UA UAA201014583A patent/UA99964C2/ru unknown
-
2010
- 2010-09-28 ZA ZA2010/06891A patent/ZA201006891B/en unknown
- 2010-10-03 IL IL208382A patent/IL208382A0/en unknown
- 2010-10-26 EC EC2010010571A patent/ECSP10010571A/es unknown
- 2010-11-10 CO CO10140646A patent/CO6260135A2/es active IP Right Grant
- 2010-11-12 MA MA33361A patent/MA32312B1/fr unknown
-
2012
- 2012-10-31 CY CY20121101046T patent/CY1113577T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060230L (no) | Nye aminobenzofenonforbindelser | |
| CL2009000405A1 (es) | Compuestos derivados de pirrolo [2,3 b] pirazina, inhibidores jak y cyk; y sus usos en el tratamiento de enfermedades inflamatorias, autoinmune y cancer. | |
| EA200801362A1 (ru) | Пиримидинил бензотиофеновые соединения | |
| EA201071057A1 (ru) | Производные азетидина и циклобутана как ингибиторы jak-киназ | |
| PA8784001A1 (es) | Oxazolidinonas sustituidas y su uso | |
| TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
| MY156727A (en) | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors | |
| TW200631583A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
| EA201170161A1 (ru) | 1,2,5-оксадиазолы в качестве ингибиторов индоламин-2,3-диоксигеназы | |
| EA201290894A1 (ru) | Азетидиновые производные пиперидин-4-ила как ингибиторы jak1 | |
| DK2250172T3 (da) | Pyrrolopyrazinkinaseinhibitorer | |
| TW200700068A (en) | Phthalazine, aza-and diaza-phthalazine compounds and methods of use | |
| CY1111733T1 (el) | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri | |
| BRPI1006794A8 (pt) | Processos para preparar inibidores jak | |
| CO6311079A2 (es) | Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer | |
| ATE517107T1 (de) | Pyrrolopyrazinkinaseinhibitoren | |
| MY176944A (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
| EA201400245A1 (ru) | Ингибиторы dyrk1 и их применение | |
| TW200635597A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
| EA201170672A1 (ru) | Соединения, пригодные для лечения целлюлита | |
| CY1113577T1 (el) | ΣΥΝΘΕΣΗ ΔΙΥΔΡΟΘΕΙΕΝΟ[3,2-d]ΠΥΡΙΜΙΔΙΝΟ ΔΙΟΛΩΝ ΚΑΙ ΠΑΡΟΜΟΙΩΝ ΠΥΡΙΜΙΔΙΝΟ ΔΙΟΛΩΝ | |
| TW200633711A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
| CY1108718T1 (el) | Ενισχυται υποδοχεως αμρα | |
| ATE501124T1 (de) | Phthalazin-, aza- und diazaphthalazinverbindungen und anwendungsverfahren | |
| DK1893597T3 (da) | AMPA-receptorpotentiatorer |